Us Bancorp \De\ Biomarin Pharmaceutical Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 7,390 shares of BMRN stock, worth $492,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,390

Previous 11,732 37.01%

Holding current value

$492,395

Previous $965,000 46.22%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$69.02 - $93.84 $299,684 - $407,453	-4,342 Reduced 37.01%	7,390 $519,000
Q2 2024 Aug 06, 2024	BUY	$74.43 - $92.22 $1,563 - $1,936	21 Added 0.18%	11,732 $965,000
Q1 2024 May 07, 2024	SELL	$83.81 - $99.0 $211,117 - $249,381	-2,519 Reduced 17.7%	11,711 $1.02 Million
Q4 2023 Feb 09, 2024	SELL	$76.22 - $98.51 $3.94 Million - $5.09 Million	-51,646 Reduced 78.4%	14,230 $1.37 Million
Q3 2023 Nov 03, 2023	BUY	$85.07 - $94.48 $4 Million - $4.44 Million	47,007 Added 249.12%	65,876 $5.83 Million
Q2 2023 Aug 09, 2023	SELL	$86.68 - $100.3 $674,977 - $781,036	-7,787 Reduced 29.21%	18,869 $1.64 Million
Q1 2023 May 09, 2023	SELL	$87.74 - $117.27 $2,193 - $2,931	-25 Reduced 0.09%	26,656 $2.59 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $293,775 - $394,326	3,630 Added 15.75%	26,681 $2.76 Million
Q3 2022 Oct 27, 2022	SELL	$82.16 - $96.94 $47,406 - $55,934	-577 Reduced 2.44%	23,051 $1.95 Million
Q2 2022 Aug 01, 2022	SELL	$71.48 - $86.85 $422,017 - $512,762	-5,904 Reduced 19.99%	23,628 $1.96 Million
Q1 2022 May 11, 2022	BUY	$74.28 - $92.69 $141,132 - $176,111	1,900 Added 6.88%	29,532 $2.28 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $183,388 - $233,888	2,557 Added 10.2%	27,632 $2.44 Million
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $5,084 - $5,811	-68 Reduced 0.27%	25,075 $1.94 Million
Q2 2021 Aug 05, 2021	SELL	$75.51 - $84.79 $219,583 - $246,569	-2,908 Reduced 10.37%	25,143 $2.1 Million
Q1 2021 Apr 28, 2021	SELL	$74.73 - $90.69 $1.98 Million - $2.4 Million	-26,517 Reduced 48.59%	28,051 $2.12 Million
Q4 2020 Feb 04, 2021	BUY	$72.61 - $90.2 $759,645 - $943,672	10,462 Added 23.72%	54,568 $4.79 Million
Q3 2020 Nov 10, 2020	SELL	$71.87 - $131.03 $71,798 - $130,898	-999 Reduced 2.21%	44,106 $3.36 Million
Q2 2020 Aug 07, 2020	BUY	$79.55 - $124.22 $171,032 - $267,073	2,150 Added 5.01%	45,105 $5.56 Million
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $52,813 - $71,669	740 Added 1.75%	42,955 $3.63 Million
Q4 2019 Feb 04, 2020	BUY	$64.27 - $86.37 $1.83 Million - $2.46 Million	28,487 Added 207.51%	42,215 $3.57 Million
Q3 2019 Nov 08, 2019	BUY	$67.4 - $85.11 $308,085 - $389,037	4,571 Added 49.92%	13,728 $925,000
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $83,564 - $97,656	-1,040 Reduced 10.2%	9,157 $785,000
Q1 2019 May 08, 2019	BUY	$84.2 - $98.62 $8,083 - $9,467	96 Added 0.95%	10,197 $905,000
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $10,498 - $13,895	-131 Reduced 1.28%	10,101 $860,000
Q3 2018 Nov 01, 2018	SELL	$93.92 - $105.72 $58,136 - $65,440	-619 Reduced 5.7%	10,232 $993,000
Q2 2018 Aug 08, 2018	BUY	$76.01 - $99.03 $43,781 - $57,041	576 Added 5.61%	10,851 $1.02 Million
Q1 2018 May 08, 2018	BUY	$77.67 - $92.63 $1,631 - $1,945	21 Added 0.2%	10,275 $833,000
Q4 2017 Feb 02, 2018	BUY	$80.76 - $95.13 $20,028 - $23,592	248 Added 2.48%	10,254 $915,000
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $806,483 - $950,069	10,006	10,006 $931,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account